HighQu
Private Company
Funding information not available
Overview
HighQu is a privately-held, revenue-generating German company that develops and sells high-quality molecular biology kits and reagents for research and diagnostic applications. Its core strength lies in enzymes and kits optimized for direct amplification from crude samples, reducing sample preparation time, alongside a portfolio of standard PCR reagents, electrophoresis products, and unique offerings like non-toxic DNA stains. The company emphasizes a 'professionally simple' philosophy, combining robust product performance with streamlined protocols and responsive customer support, and has built a global distribution network since its founding in 2016.
Technology Platform
Optimized enzyme engineering and formulation for nucleic acid amplification, with a focus on robust enzymes for direct PCR from crude samples and isothermal amplification.
Opportunities
Risk Factors
Competitive Landscape
HighQu competes in the crowded molecular biology reagents market against global giants like Thermo Fisher, Qiagen, and Bio-Rad, as well as numerous specialty manufacturers. It differentiates through a focus on premium, robust enzymes for challenging applications like direct PCR and a customer-centric 'professionally simple' service model.